Clinical Report: Autoimmune Disorders Among Patients with Varied Phenotypes of PCOS
Overview
This study investigates the prevalence of autoimmune disorders among women with polycystic ovary syndrome (PCOS) and explores the relationship between different PCOS phenotypes and autoimmune susceptibility. Findings indicate that 22.6% of PCOS patients have organ-specific or systemic autoimmune disorders, with a notable prevalence of autoimmune thyroiditis.
Background
Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder associated with reproductive and metabolic complications. Understanding the relationship between PCOS and autoimmune disorders is crucial, as autoimmune diseases disproportionately affect women and can complicate the management of PCOS. This study aims to clarify these interrelations to improve patient outcomes.
Data Highlights
Autoimmune Disorder
Prevalence in PCOS Patients
Autoimmune Thyroiditis
20.3%
Subclinical/Overt Hypothyroidism
13.45%
Hyperthyroidism
1%
Non-Thyroid Autoimmune Disorders
2.3%
Psoriasis
0.48%
Type 1 Diabetes Mellitus
0.32%
Alopecia Areata
0.24%
Rheumatoid Arthritis
0.24%
Key Findings
The prevalence of autoimmune thyroiditis in PCOS women is 20.3%.
Obese PCOS patients have a higher prevalence of autoimmune thyroiditis (23.6%) compared to non-obese patients (18.6%).
Subclinical or overt hypothyroidism is present in 13.45% of PCOS patients.
Only 2.3% of PCOS women have concomitant non-thyroid autoimmune disorders.
The most common non-thyroid autoimmune disorders in the cohort include psoriasis and type 1 diabetes mellitus.
Clinical Implications
Clinicians should consider screening for autoimmune disorders, particularly thyroid conditions, in women diagnosed with PCOS, especially those who are obese. Awareness of the increased risk for autoimmune diseases can guide more comprehensive management strategies for PCOS patients.
Conclusion
The study highlights a significant association between PCOS and autoimmune disorders, emphasizing the need for further research to explore these interrelations and improve clinical management of affected patients.
